Clinical Trial

A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

Name: A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes — clinical trial record (NCT07126873)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety, tolerability and efficacy of E-islet 01 in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-10.

Trial Details

NCT Number	NCT07126873
Lead Sponsor	EndoCell Therapeutics, Inc.
Conditions	Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
Enrollment	21 participants
Start Date	2025-08-11
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-22